Table 1.

Clinical Studies on the Efficacy of TCM in the Treatment of HCC

Medication	Patients (Cases)	Enrolling Condition	Effect	Reference
Huaier granule	686	Patient underwent curative resection of HCC	Reduce recurrence rate and prolong recurrence-free survival	[14]
	62	Patients diagnosed with HCC	Prolong survival, reduce the number of interventional treatment and improve the tumor response rate	[16]
JPLQ	150	Patients with unresectable HCC who had received TACE treatment	Relieve the Postembolization syndrome, improve the QoL of patients after TACE, and repair liver function damage	[17]
CHHJ	125	Patients with unresectable HCC who has received TACE treatment	Improve 3-year overall survival and reduce the occurrence of side effects after TACE	[19]
BXXX	68	Adults with advanced HCC	Achieve the median PFS of 6.07 months	[20]
ESQJR	137	Patients with HCC underwent tumor resection	Improve the prognosis and tumor recurrence	[21]
Jie Du granule	177	Patients with advanced HCC	Prolong survival of patients with advanced HCC	[23]
	190	HCC patients with PVTT	Prolong survival in HCC-PVTT patients	[24]

Abbreviations: HCC, hepatocellular carcinoma; TCM, traditional Chinese medicine; TACE, transcatheter arterial chemoembolization; JPLQ, Jian Pi Li Qi decoction; CHHJ, Chaihu Huaji decoction; BXXX, Banxia XieXin decoction; ESQJR, Erzhu Qinggan Jiedu Recipe; PFS, progression-free survival; QoL, quality of life.